Brendan Kelly to In Situ Hybridization, Fluorescence
This is a "connection" page, showing publications Brendan Kelly has written about In Situ Hybridization, Fluorescence.
Connection Strength
0.121
-
New methods for ALK status diagnosis in non-small-cell lung cancer: an improved ALK immunohistochemical assay and a new, Brightfield, dual ALK IHC-in situ hybridization assay. J Thorac Oncol. 2013 Aug; 8(8):1019-31.
Score: 0.121